Indel Therapeutics' Series B Round

Indel Therapeutics raised a round of funding on April 28, 2011.

Indel Therapeutics Inc. is a Vancouver-based biotechnology company dedicated to discovering and developing drugs for difficult to treat infections, with a focus on the growing critical unmet needs of …

Articles about Indel Therapeutics' Series B Round: